Type A and B Monoamine Oxidase in Age-Related Neurodegenerative Disorders: Their Distinct Roles in Neuronal Death and Survival

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 20, 2012-10 ,pp. : 2177-2188

Bentham Science Publishers

Access to resources Recommend Favorite

The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents

By  

Current Medicinal Chemistry, Vol. 18, Iss. 33, 2011-11 ,pp. : 5114-5144

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine oxidase A and B inhibitors

By Jegham S.   George P.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1143-1150

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells

By Abu-Raya S.   Tabakman R.   Blaugrund E.   Trembovler V.   Lazarovici P.  

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-01 ,pp. : 777-785

Bentham Science Publishers

Access to resources Recommend Favorite